These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 7891119)

  • 21. Alzheimer's disease: relationship between muscarinic cholinergic receptors, beta-amyloid and tau proteins.
    Pavía J; de Ceballos ML; Sanchez de la Cuesta F
    Fundam Clin Pharmacol; 1998; 12(5):473-81. PubMed ID: 9794144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Z-IQNP: a potential radioligand for SPECT imaging of muscarinic acetylcholine receptors in Alzheimer's disease.
    Nobuhara K; Halldin C; Hall H; Karlsson P; Farde L; Hiltunen J; McPherson DW; Savonen A; Bergström KA; Pauli S; Swahn CG; Larsson SA; Schnell PO; Sedvall G
    Psychopharmacology (Berl); 2000 Mar; 149(1):45-55. PubMed ID: 10789882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ontogeny of m1-m5 muscarinic receptor subtypes in rat forebrain.
    Wall SJ; Yasuda RP; Li M; Ciesla W; Wolfe BB
    Brain Res Dev Brain Res; 1992 Apr; 66(2):181-5. PubMed ID: 1606683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of [3H]4-DAMP binding to muscarinic receptors in the orbitofrontal cortex of Alzheimer's disease patients with psychosis.
    Tsang SW; Francis PT; Esiri MM; Wong PT; Chen CP; Lai MK
    Psychopharmacology (Berl); 2008 Jun; 198(2):251-9. PubMed ID: 18373228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of antisera selective for m1 muscarinic receptors using fusion proteins: distribution of m1 receptors in rat brain.
    Wall SJ; Yasuda RP; Hory F; Flagg S; Martin BM; Ginns EI; Wolfe BB
    Mol Pharmacol; 1991 May; 39(5):643-9. PubMed ID: 2034236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional alterations in M1 muscarinic receptor-G protein coupling in Alzheimer's disease.
    Ladner CJ; Celesia GG; Magnuson DJ; Lee JM
    J Neuropathol Exp Neurol; 1995 Nov; 54(6):783-9. PubMed ID: 7595651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of muscarinic receptor subtypes in rat brain from postnatal to old age.
    Tice MA; Hashemi T; Taylor LA; McQuade RD
    Brain Res Dev Brain Res; 1996 Mar; 92(1):70-6. PubMed ID: 8861724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
    Buckley NJ; Bonner TI; Buckley CM; Brann MR
    Mol Pharmacol; 1989 Apr; 35(4):469-76. PubMed ID: 2704370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intact coupling of M1 receptors and preserved M2 and M4 receptors in the cortex in progressive supranuclear palsy: contrast with other dementias.
    Warren NM; Piggott MA; Lees AJ; Perry EK; Burn DJ
    J Chem Neuroanat; 2008 May; 35(3):268-74. PubMed ID: 18282687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-related changes of muscarinic cholinergic receptor subtypes in the striatum of Fisher 344 rats.
    Tayebati SK; Di Tullio MA; Amenta F
    Exp Gerontol; 2004 Feb; 39(2):217-23. PubMed ID: 15036415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normal sequences of muscarinic acetylcholine receptors (m1 and m2) in patients with Alzheimer's disease and vascular dementia.
    Ohara K; Kondo N; Xie D; Tanabe K; Yamamoto T; Kosaka K; Miyasato K; Ohara K
    Neurosci Lett; 1994 Aug; 178(1):23-6. PubMed ID: 7816331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Muscarinic receptors and novel strategies for the treatment of age-related brain disorders.
    Ehlert FJ; Roeske WR; Yamamura HI
    Life Sci; 1994; 55(25-26):2135-45. PubMed ID: 7997072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential regulation of subtypes m1-m5 of muscarinic receptors in forebrain by chronic atropine administration.
    Wall SJ; Yasuda RP; Li M; Ciesla W; Wolfe BB
    J Pharmacol Exp Ther; 1992 Aug; 262(2):584-8. PubMed ID: 1323653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional covariance of muscarinic acetylcholine receptors in Alzheimer's disease using (R, R) [(123)I]-QNB SPECT.
    Colloby SJ; McKeith IG; Wyper DJ; O'Brien JT; Taylor JP
    J Neurol; 2015 Sep; 262(9):2144-53. PubMed ID: 26122542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ligand binding properties of muscarinic acetylcholine receptor subtypes (m1-m5) expressed in baculovirus-infected insect cells.
    Dong GZ; Kameyama K; Rinken A; Haga T
    J Pharmacol Exp Ther; 1995 Jul; 274(1):378-84. PubMed ID: 7616422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of muscarinic M4 receptors in hippocampus of Alzheimer patients.
    Mulugeta E; Karlsson E; Islam A; Kalaria R; Mangat H; Winblad B; Adem A
    Brain Res; 2003 Jan; 960(1-2):259-62. PubMed ID: 12505680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex.
    Kellar KJ; Whitehouse PJ; Martino-Barrows AM; Marcus K; Price DL
    Brain Res; 1987 Dec; 436(1):62-8. PubMed ID: 3690354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
    Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies.
    Levey AI; Kitt CA; Simonds WF; Price DL; Brann MR
    J Neurosci; 1991 Oct; 11(10):3218-26. PubMed ID: 1941081
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.